Extension to the Study of Efficacy of CDZ173 in Patients With APDS/PASLI
Clinical trial NCT02859727 · TERMINATED
Trial details
- NCT number
- NCT02859727
- Sponsor
- Pharming Technologies B.V.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2025-01-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.